
|Articles|November 1, 2002
Polygenic Theory
Only 10 percent of PSORS1 carriers affectedPhysician: James T. Elder, M.D., Ph.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus
2
The Aesthetic Edge: January 2026
3
Case-Based Perspectives on Biologic Treatment for Hidradenitis Suppurativa
4
LEVEL UP Study Shows Benefits of Switching From Dupilumab to Upadacitinib in AD
5



















